Clinical Trial Update: Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 trial update for glioblastoma multiforme evaluating Subventricular Zone-targeted therapy in combination with temozolomide; the study is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Glioblastoma Multiforme | Phase 2 | Status: ACTIVE_NOT_RECRUITING